The BRAVO Study: Cost Neutrality in Cystoscopy for Bladder Cancer Patients Presented at SUO 2025 The latest findings from the BRAVO study showcase the cost neutrality of blue light versus white light cystoscopy in treating bladder cancer, emphasizing real-world savings.

The BRAVO Study: Cost Neutrality in Cystoscopy for Bladder Cancer Patients Presented at SUO 2025 #Norway #Oslo #Bladder_Cancer #Photocure_ASA #BRAVO_Study